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Vault is a 12.9 MDa ribonucleoprotein particle with a barrel-
like shape, two protruding caps and an invaginated waist
structure that is highly conserved in a wide variety of
eukaryotes. Multimerization of the major vault protein
(MVP) is sufﬁcient to assemble the entire exterior shell of
the barrel-shaped vault particle. Multiple copies of two
additional proteins, vault poly(ADP-ribose) polymerase
(VPARP) and telomerase-associated protein 1 (TEP1), as
well as a small vault RNA (vRNA), are also associated with
vault. Here, the crystallization of vault particles is reported.
The crystals belong to space group C2, with unit-cell
parameters a = 708.0, b = 385.0, c = 602.9 A ˚ ,   = 124.8 .
Rotational symmetry searches based on the R factor and
correlation coefﬁcient from noncrystallographic symmetry
(NCS) averaging indicated that the particle has 39-fold
dihedral symmetry.
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1. Introduction
Vault is a large ribonucleoprotein particle with a unique
barrel-shaped structure that is widely conserved among
eukaryotes (Kedersha & Rome, 1986). Vault has a molecular
weight of 12.9 MDa and overall dimensions of 400   400  
700 A ˚ , both of which were determined by scanning transmis-
sion electron microscopy (Kedersha et al., 1991). In mammals,
vaults contain three major proteins: the 100 kDa major vault
protein (MVP; Kedersha & Rome, 1986), the 193 kDa vault
poly(ADP-ribose) polymerase (VPARP; Kickhoefer, Siva et
al., 1999) and the 240 kDa telomerase-associated protein 1
(TEP1; Kickhoefer, Stephen et al., 1999). Additionally, the
complex contains vRNA, a small RNA molecule (Kickhoefer
et al., 1993).
MVP accounts for more than 75% of the particle mass
(Kedersha et al., 1991). Interestingly, expression of MVP alone
in insect cells leads to the assembly of recombinant MVP-only
vault, demonstrating that the multimerization of this single
protein is sufﬁcient to form the exterior shell of the vault
particle (Stephen et al., 2001). VPARP is a poly(ADP-ribose)
polymerase (PARP) family member that possesses a canonical
PARP domain (Kickhoefer, Siva et al., 1999) and is capable of
ADP-ribosylating itself and MVP. However, the physiological
roles of these modiﬁcations are still unknown. Although vault
particles do not show telomerase activity, experimental data
suggest that TEP1 is important for vRNA binding and stabi-
lization of the vault complex (Kickhoefer et al., 2001).
Although vRNA comprises less than 5% of the vault mass, it
forms important interactions with other cellular components
(Kickhoefer et al., 2002) as well as with anticancer antibiotics
such as mitoxantrone (Gopinath et al., 2005).In some tumour and immune cells, vault expression corre-
lates with resistance to a variety of structurally and chemically
unrelated cytotoxins (Izquierdo et al., 1996; Kickhoefer et al.,
1998; Scheffer et al., 1995; Scheper et al., 1993; Schroeijers et
al., 2002). The hollow nature of vaults, as well as their
subcellular localization at multiple sites, including the
nucleolus (Hamill & Suprenant, 1997), nuclear pore com-
plexes (Chugani et al., 1993) and the cytosol, in which the
particles transiently interact with microtubules (Eichenmu ¨ller
et al., 2003), point to a role in nucleocytoplasmic transport. In
MVP-knockout mice, however, MVP
 /  cells do not show
increased sensitivity to various cytostatic agents (Mossink et
al., 2002). Thus, the function of the vault particle has remained
elusive.
Freeze-etch electron microscopy of vault from rat liver has
revealed that each vault particle appears as an open pair of
ﬂower-like structures, each with eight petals (Kedersha et al.,
1991). Imposing eightfold symmetry, Kong et al. (1999)
analyzed the structure of rat vault using a cryoelectron-
microscopic method. This revealed the reconstructed structure
of the rat vault to be a hollow barrel-like structure with two
protruding caps and an invaginated waist; 96 copies of MVP
were predicted to form the barrel-shaped core of the particle.
Difference mapping between RNase-treated and intact vaults
revealed that vRNA is localized at the end of the vault caps
(Kong et al., 2000). This led the authors to propose a model of
the complex that has eightfold dihedral symmetry (point
group D8) and that contains one copy of TEP1, four copies of
VPARP and three or more copies of vRNA in each cap. One
reconstituted structure of recombinant vault with a cysteine-
rich tag displayed 48-fold rotational symmetry, even though
only eightfold symmetry was imposed during image processing
(Mikyas et al., 2004). The reconstituted structures of the
recombinant vault particles have led the authors to propose a
model with D48 point-group symmetry and with the MVP
N-termini located in the vault midsection.
Rat vault exhibits a crystallographic sixfold dihedral sym-
metry as a two-dimensional crystal, whereas monkey vault
exhibits a crystallographic threefold dihedral symmetry as a
three-dimensional crystal (Querol-Audı ´ et al., 2005). These
sixfold and threefold rotational symmetries agree with the
48-fold symmetry for reconstituted recombinant vault (Mikyas
et al., 2004).
In this study, we crystallized vault particles from rat liver in
several crystalline forms. Crystallographic studies of a mono-
clinic crystal, which did not have crystallographic threefold,
fourfold and sixfold axes, are described in this paper. Our
results demonstrate that vault has a 39-fold rotational axis.
2. Materials and methods
2.1. Purification and crystallization
Vault was puriﬁed from rat liver as described by Kong et al.
(1999). The protein concentration was determined using a
BCA Protein Assay Kit (Pierce). The vault puriﬁed from a
CsCl density-gradient fraction was dialyzed against buffer
containing 50 mM Tris pH 7.5, 75 mM NaCl and 1.5 mM
MgCl2 and then concentrated to 10–80 mg ml
 1 in an ultra-
ﬁltration cell (Orbital Biosciences, 150 kDa cutoff). Puriﬁed
particles were veriﬁed by negative staining with 2% uranyl
acetate followed by examination under an electron micro-
scope (H-7650; Hitachi) and also by SDS–PAGE.
Vault was crystallized using the hanging-drop vapor-diffu-
sion method at 277 or 288 K. A hanging drop was prepared by
mixing equal volumes of vault solution and precipitant solu-
tion containing polyethylene glycol (PEG).
2.2. X-ray diffraction data collection
Prior to X-ray diffraction at cryogenic temperatures, crys-
tals were soaked in a solution containing a higher concentra-
tion of PEG than that in the crystallization precipitant
solution, which prevented the formation of ice at cryogenic
temperatures. The PEG concentration was increased stepwise
from that of the crystallization precipitant solution until it
reached the ﬁnal concentration. The crystals were frozen by
ﬂash-cooling after incubation in the PEG solution overnight.
X-ray experiments were performed at 100 K with a DIP6040
imaging-plate detector (MAC Science/Bruker AXS) on the
BL44XU beamline of the SPring-8 synchrotron facility
(Harima, Hyogo, Japan). The oscillation angle of each shot
was 0.3 . After ﬁve successive shots had been taken without
translation of the crystal, the crystal was translated by 100 mm
along its rotation axis to reduce radiation damage (the X-ray
beam size was 50   50 mm). Diffraction data were integrated
using MOSFLM (Leslie, 1992) and scaled using SCALA
(Evans, 1997). Observed structure factors were evaluated with
TRUNCATE (French & Wilson, 1978).
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Figure 1
(a) SDS–PAGE of puriﬁed rat vault. Gels are silver-stained. (b)
Negatively stained rat vault visualized by transmission electron micro-
scopy. The sample was adsorbed onto a carbon-coated grid, stained with
2% uranyl acetate and air-dried. Scale bar, 100 nm.2.3. Electron-microscopic analysis
Puriﬁed protein was embedded in vitreous ice by rapid
plunging into liquid ethane using a Leica EM CPC (Leica
Microsystems, Wetzlar, Germany). All images were acquired
using a JEOL3000SFF electron microscope (Jeol; Tokyo,
Japan) equipped with a liquid-helium stage and operated at
200 kV. Electron micrographs were recorded on Kodak
SO-163 ﬁlm at a magniﬁcation of  40 000. Micrographs were
scanned on a Nikon SUPER COOLSCAN9000 at 4000 dpi,
which corresponded to 6.35 mm per pixel. Three-dimensional
reconstruction of vault particles to produce an initiator model
was performed using IMAGIC (van Heel et al., 1996). D6
symmetry was assumed throughout the processing. The
effective resolution of the ﬁnal three-dimensional recon-
struction was 37 A ˚ based on a 0.5 cutoff of the Fourier shell
correlation (van Heel, 1987). Low-pass ﬁltered three-dimen-
sional reconstruction to 37 A ˚ resolution was performed
following X-ray crystallographic analysis. Prior to use of the
reconstituted structure for molecular-replacement analysis, it
was modiﬁed by averaging the electron densities at equal
distances from the central axis of the vault particle. Conse-
quently, the modiﬁed model (EM model) had a circular
symmetry.
2.4. Rotational symmetry search
Self-rotation functions were calculated to determine the
rotational symmetry elements of the vault particles with the
fast-rotation function and slow-rotation function programs of
GLRF (Tong & Rossmann, 1997). The Patterson integration
radius was 50 A ˚ and data in the resolution range 50–10 A ˚ were
used.
In addition to rotation-function calculations, phase reﬁne-
ments from NCS averaging were used to conﬁrm the rota-
tional symmetry elements. NCS averaging was performed
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Figure 2
Photographs of vault crystals. (a) Crystal A.( b) Triclinic crystal B.( c) Monoclinic crystal C.( d) Monoclinic crystal D.( e) Tetragonal crystal E.( f) Crystal
F. Scale bars, 0.1 mm.
Table 1
Crystallization conditions.
Crystal
Protein
concentration†
(mg ml
 1) Reservoir solution
A 40 15% PEG 400, 0.8 M NaCl, 50 mM Li2SO4
in 50 mM Tris–HCl pH 8.0
B 5 4% PEG 4000, 50 mM KCl, 25% ethylene
glycol (EG) in 50 mM Tris–HCl pH 7.0
C 5 4% PEG 2000, 50 mM KCl, 25% EG in
50 mM Tris–HCl pH 7.0
D 40 2.4% PEG 4000, 0.8 M NaCl, 50 mM Li2SO4
in 50 mM Tris–HCl pH 8.0
E 5 4% PEG 3350, 50 mM ammonium acetate,
25% EG
F 5 3% PEG 8000, 50 mM KCl, 25% EG
in 50 mM Tris–HCl pH 7.0
† Vault was dissolved in buffer containing 50 mM Tris–HCl pH 7.5, 75 mM NaCl and
1.5 mM MgCl2. The crystallization temperature for crystals A, D and E was 288 K and
that for crystals B, C and F was 277 K.using the RAVE package from the Uppsala Software Factory
(Kleywegt et al., 2001).
3. Results and discussion
3.1. Purification and crystallization of vault
The vault samples obtained following several density-
gradient centrifugations of rat liver samples were highly pure
(Figs. 1a and 1b). Negatively stained electron-microscopic
images showed barrel-like structures as previously reported
(Kedersha & Rome, 1986). Puriﬁed vault particles were
subjected to various crystallization conditions. Six different
types of crystals were obtained with a variety of precipitant
conditions. These crystals are referred to as A, B, C, D, E and
F in this paper (Fig. 2). Crystallization conditions are given in
Table 1. Thick crystals were grown in conditions that
employed lower molecular-weight PEGs. Because we
successfully identiﬁed freezing procedures for crystals B, C, D
and E, X-ray experiments were performed with these crystals.
Crystal B belonged to space group P1, with unit-cell para-
meters a = 442.0, b = 598.7, c = 638.9 A ˚ ,   = 68.1,   = 78.2,
  = 70.3 ; they diffracted to 10 A ˚ resolution. We were not able
to improve the quality of crystal B despite making adjustments
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Figure 3
Packing of vault particles with dimensions 400   400   700 A ˚ in crystal D with unit-cell parameters a = 708.0, b= 385.0, c= 602.9 A ˚ ,  = 124.8 . Packing is
shown (a) in the ac plane, (b) in the ab plane, (c) parallel to the N-fold rotation axis and (d) perpendicular to the N-fold rotation axis. A surface-rendered
three-dimensional image of vault was obtained from cryoelectron microscopy and single-particle reconstruction.to the original crystallization conditions. Crystal C was a
monoclinic crystal belonging to space group P21, with unit-cell
parameters a = 390, b = 545, c = 672 A ˚ ,   =9 4  . The crystal-
lization conditions for crystal D were almost identical to those
described by Querol-Audı ´ et al. (2005). In 2–3 weeks, these
crystals grew to as large as 1 mm in their longest dimension
and diffracted to 8.0 A ˚ resolution. The crystals belonged to
space group P21, with unit-cell parameters a = 599.8, b= 385.0,
c = 616.4 A ˚ ,  =1 0 9 . 1  . The orientation of the vault particles in
these crystals changed when they were soaked in cryo-
protectant using another buffer condition, which caused the
crystals to adopt space group C2, with unit-cell parameters
a = 708.0, b = 385.0, c = 602.9 A ˚ ,   = 124.8 . Crystal E was a
tetragonal crystal belonging to space group P4, with unit-cell
parameters a = b = 625, c = 767 A ˚ . Of these crystals, crystal D
in space group C2 produced the best diffraction results; thus,
the following descriptions are restricted to that crystal form.
3.2. Symmetry of vault
A total of 38 crystals were used to collect 1175 frames of
diffraction images. The statistics of the intensity data for
native crystals are given in Table 2. Intensity data to 10.0 A ˚
resolution were acquired with 99.9% completeness and with
an Rmerge value of 0.102. The native Patterson function
calculated at 20 A ˚ resolution showed no prominent peaks
except at the origin and at (1/2, 1/2, 0), corresponding to the
face-centred symmetry operation. The self-rotation function
(described precisely below) located the principal rotation axis
on the ac plane and a twofold axis parallel to the b axis.
Particles with dimensions 400   400   700 A ˚ were well packed
in the crystalline lattice (Fig. 3). When half of a particle was
packed in an asymmetric unit, the particles packed tightly and
each particle did not markedly overlap with its neighbours in
the crystal. Consequently, a VM value of 5.18 A ˚ 3 Da
 1 was
conﬁrmed, which is outside the typical range for soluble
proteins (2.5–3.5 A ˚ 3 Da
 1; Matthews, 1968), probably owing
to the hollow nature of the particle.
The self-rotation functions were calculated at 10 A ˚ resolu-
tion using the fast-rotation function and the slow-rotation
function software GLRF (Tong & Rossmann, 1997). Using
reﬂections in the resolution range 50–10 A ˚ , each rotation
function was calculated at an equal step of 1.0  with an inte-
gration radius of 50 A ˚ . Twofold rotational symmetries are
shown in   = 180  sections of stereo diagrams in Fig. 4. Fig. 5
shows plots of the rotation functions against   at (’,  )=
(90 , 110 ). There were multiple twofold symmetry axes with a
strong peak in the stereographic drawings of the   = 180 
section; the axes were perpendicular to the rotation axis at
(’,  ) = (90 , 110 ). The fast-rotation function is plotted
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Figure 4
Stereo diagrams of (a) the fast-rotation function and (b) the slow-rotation
function for twofold rotational symmetry (  = 180  section) in the 50–
10 A ˚ resolution range. Contours were drawn at equal intervals of 0.5 .
Table 2
Intensity data.
Values in parentheses are for the highest shell.
Resolution (A ˚ ) 210–10.0 (10.5–10.0)
Total No. of frames 1175
Total No. of reﬂections 613655
Unique reﬂections 71967
Completeness (%) 99.9 (100.0)
Multiplicity 8.5 (8.8)
I/ (I) 18.4 (17.7)
Rmerge† 0.102 (0.113)
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the observed
intensity and hI(hkl)i is the averaged intensity over equivalent reﬂections from different
measurements.against   at (’,  ) = (90 , 110 ) with broad peaks at   =6 0  ,
120  and 180 , indicating that the particle had a sixfold rota-
tion symmetry axis at (’,  ) = (90 ,1 1 0  ) (Fig. 5). Multiple
twofold symmetry axes perpendicular to the sixfold rotation
axis were detected every 30  (Fig. 4a). The fast-rotation
function calculation at 10 A ˚ resolution indicated that the
particle exhibited point group D6. The section at   = 180 
(Fig. 4b) and the plot against   at (’,  ) = (90 , 110 ) (Fig. 5)
were calculated using the slow-rotation function. Although
Fig. 4(b) shows multiple twofold axes perpendicular to the
rotational axis at (’,  ) = (90 , 110 ) as observed in Fig. 4(a),
six peaks were not detected, which contrasted with the results
obtained with the fast-rotation function. The slow-rotation
function plot shows a number of peaks at intervals of 360 /39,
indicating 39-fold symmetry. However, there is an additional
peak at 60  that would be in conﬂict with 39-fold symmetry.
The plot did not show a clear peak at   = 180 , which was one
of the essential peaks for D6 symmetry. Consequently, the
rotational symmetry of vault was not consistently determined
using the two rotation functions.
To determine the rotational symmetry at (’, ’) = (90 ,
110 ), phase reﬁnements were performed using NCS aver-
aging by assuming twofold to 48-fold rotational symmetry.
Initial phases were calculated at 30 A ˚ resolution using the EM
model and phase extension was performed to 10 A ˚ resolution.
R factors and correlation coefﬁcients between observed and
calculated structure factors from each NCS averaging are
plotted in Fig. 6. The R factors at the threefold, 13-fold and
39-fold symmetries were signiﬁcantly smaller than their
neighbouring symmetries and the correlation coefﬁcients
exhibited signiﬁcantly higher peaks at the threefold, 13-fold
and 39-fold symmetries. Although an R factor and correlation
coefﬁcient for sixfold symmetry were observed in local peaks,
these criteria were less signiﬁcant than those for the threefold,
13-fold and 39-fold symmetries.
Fig. 3 shows the packing of vaults in the crystal. Because the
large vault particles (400   40   700 A ˚ ) were very thin, at
about 30 A ˚ , the ratio of the cross-vector and the self-vector of
the Patterson function within a radius of 50 A ˚ is higher than
that usually observed for crystals consisting of spherical
proteins. The large peak at   =6 0   detected with both the fast-
rotation and slow-rotation function may have been caused by
the packing of the vault particles, which exhibited a hexagonal
arrangement in the projection along the principal rotational
axis (Fig. 3c).
Rat liver vault in a crystalline state showed D39 symmetry.
To our knowledge, such 39-fold symmetry has not been
previously detected in any supramolecular complex. The
eightfold symmetry observed in the half vault particle from rat
(Kedersha et al., 1991), the 48-fold rotation symmetry of the
rat recombinant vault particle elucidated by cryoelectron
microscopy (Mikyas et al., 2004) and the D6 symmetry of rat
vault (Querol-Audı ´ et al., 2005) were not detected in the
present study of rat liver vault. Of note, three-dimensional
crystals of monkey vault exhibit crystallographic D3 symmetry
(Querol-Audı ´ et al., 2005) consistent with the 39-fold
symmetry observed in the present study.
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